Latest Breaking News On - Biotechnology research and information network - Page 1 : comparemela.com

B R A I N Biotechnology Research And Information Network AG: BRAIN AG Q1 20/ 21 Results

DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG / Key word(s): Quarter Results 26.02.2021 / 07:30 Zwingenberg, Germany, 26. February 2021 BRAIN AG Q1 20/ 21 Results Strong performance of Biocatalysts Solid Cash Position Today, B.R.A.I.N. Biotechnology Research and Information Network AG (BRAIN AG, ISIN DE0005203947 / WKN 520394) published its results for the first quarter of the financial year 2020/21. Group revenues in the reporting period from October 1, 2020 to December 31, 2020 decreased by 21.7 % to € 8.1 million from € 10.3 million. This is mainly attributable to the BioScience segment which has a highly volatile revenue recognition quarter on quarter due to timing effects and milestone payments. The Group adjusted EBITDA decreased to € -1.4 million from € -0.2 million in the first three months of the 2020/21 financial year.

Lukas linnigWeissbiotech gmbMichael schneidersStephanie konleBiocatalysts ltdInformation networkPr corporate communicationsStandard of the frankfurt stock exchangeB ra in biotechnology researchDistribution servicesBusiness developmentBiotechnology research and information networkQuarter resultsBiotechnology researchWeissbiotech gmbhPrime standard

BRAIN AG publishes its Annual Report for the Financial Year 2019/20

BRAIN AG publishes its Annual Report for the Financial Year 2019/20 DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG / Key word(s): Annual Results 14.01.2021 / 08:00 Zwingenberg, Germany, 14 January, 2021 BRAIN AG publishes its Annual Report for the Financial Year 2019/20 Today, B.R.A.I.N. Biotechnology Research and Information Network AG ( BRAIN AG ) published its annual report 2019/20 including the detailed consolidated financial statements for the financial year 2019/20. The BRAIN Group reported 3.4% organic revenue growth despite the challenging economic environment leading to consolidated revenues of EUR 38.2 million in the past financial year. Total operating performance in the reporting period from October 1st, 2019 to September 30th, 2020 has been at EUR 39.2 million. Adjusted EBITDA slightly improved from EUR -2.2 million in the previous year to EUR -2.0 million due to an improved material expense ratio.

Michael schneidersStephanie konleInformation networkDevelopment agreementPr corporate communicationsBiosun biochemicals incStandard of the frankfurt stock exchangeB ra in biotechnology researchDistribution servicesBiotechnology research and information networkAnnual resultsAnnual reportFinancial yearBiotechnology researchJoint development agreementPrime standard

DGAP-AFR: B R A I N Biotechnology Research And Information Network AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß § 114, 115, 117 WpHG

DGAP-AFR: B R A I N Biotechnology Research And Information Network AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß § 114, 115, 117 WpHG
boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.

Wphg dgapBiotechnology research and information networkBiotechnology research and information network companyBiotechnology research and informationA serviceDgap financialAll datesWorldcom dgap news serviceஉயிரி தொழில்நுட்பவியல் ஆராய்ச்சி மற்றும் தகவல் வலைப்பின்னல்

B R A I N Biotechnology Research And Information Network AG: BRAIN Group expands its US products bu

Search jobs 07-Jan-2021 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN Group expands its US products business with the successful acquisition of Biosun Biochemicals Inc. DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG / Key word(s): Mergers & Acquisitions/Takeover 07.01.2021 / 08:00 Zwingenberg, Germany, January 7th, 2021 BRAIN Group expands its US products business with the successful acquisition of Biosun Biochemicals Inc. Today, BRAIN AG announced that it has acquired Biosun Biochemicals Inc., Tampa, Florida, a successful distributor, formulator and blender of enzymes, flavors, food ingredients as well as natural colors in the US market. This acquisition will further enhance the growth trajectory of BRAIN s BioIndustrial division and improve the distribution capabilities in North America.

United statesLukas linnigMichael schneidersMark messersmithStephanie konleInformation networkBiosun biochemicals incStandard of the frankfurt stock exchangeB ra in biotechnology researchBrain agb ra in biotechnology researchDistribution servicesPr corporate communicationsBiotechnology research and information networkBiosun biochemicalsBiotechnology researchFood ingredients